Meriwether Wealth & Planning’s Edwards Lifesciences EW Stock Holding History

Meriwether Wealth & Planning’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$45.5K	Buy	+527	New	+$46.8K	0.02%	272

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Meriwether Wealth & Planning's EW Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in Edwards Lifesciences (EW) in Q3 2026: 527 shares worth $45.5K. The stake represents 0.02% of the portfolio and ranks #272 among its holdings.

492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Meriwether Wealth & Planning held 527 shares of Edwards Lifesciences worth $45.5K as of Q3 2026.
Edwards Lifesciences was a new Meriwether Wealth & Planning position in Q3 2026.
Edwards Lifesciences made up 0.02% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #272 holding.
492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.